Axcelis to Begin Construction of New Manufacturing Facility in Pyeongtaek, Korea
The $35 million project adds to existing Korean operations, with production scheduled to commence in the second half of 2028.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Axcelis Technologies (Nasdaq: ACLS) announced plans to break ground on a new semiconductor equipment manufacturing facility in Pyeongtaek, Korea. The $35 million investment will expand the company's existing Korean manufacturing operations, known as the Axcelis Asia Operations Center. The new site will manufacture ion implantation equipment used in semiconductor production.
The facility will encompass approximately 200,000 square feet of total gross floor area, with warehousing, cleanrooms and a training center. Production is scheduled to commence in the second half of 2028. Axcelis said the investment is intended to strengthen its high-volume manufacturing infrastructure and expand its capacity to serve customers worldwide. The design will incorporate a lean production environment drawing on the company's equipment manufacturing experience.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate point. Forward-looking: it has not happened yet and may not happen.Planned Pyeongtaek facility expands Korean manufacturing capacity, with production scheduled to commence in the second half of 2028.
Negative
- Moderate point. Forward-looking: it has not happened yet and may not happen.$35 million investment represents spending on the new Korean manufacturing facility. 1% of market cap
Key Figures
- Facility investment
- $35 million
- New Pyeongtaek manufacturing facility
- Facility area
- Approximately 200,000 square feet
- Total gross floor area
- Production start
- Second half of 2028
- Scheduled commencement at the new facility
Historical Context
-
Previously announced a $35 million investment and second-half 2028 production plan; groundbreaking was planned for October 20.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
ion implantation technical
gross floor area technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
The Pyeongtaek site will expand Axcelis' current manufacturing operations in
President and CEO Russell Low commented, "We are proud to celebrate this pivotal moment for Axcelis and the next chapter of our growth in
Governor of Gyeonggi Province Choo Mi Ae stated, "I would like to extend my sincere congratulations on the groundbreaking of Axcelis Korea's Pyeongtaek facility. Axcelis' investment in advanced semiconductor process equipment represents a significant milestone in strengthening the position of
About Axcelis
Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for nearly 50 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.
Safe Harbor Statement:
Statements made in this press release that are not of known historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, including the risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission ("SEC"), including specifically the risk factors described in our most recent Annual Report on Form 10-K and other subsequent filings with the SEC. The Company undertakes no obligation to update the information or statements made in this press release.
CONTACTS:
Investor Relations Contact:
David Ryzhik
Senior Vice President and Interim CFO
Telephone: (978) 787-2352
Email: David.Ryzhik@axcelis.com
Press/Media Relations Contacts:
Maureen Hart
Senior Director, Corporate & Marketing Communications
Telephone: (978) 787-4266
Email: Maureen.Hart@axcelis.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/axcelis-to-begin-construction-of-new-manufacturing-facility-in-pyeongtaek-korea-302913286.html
SOURCE Axcelis Technologies, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When will Axcelis begin production at its new Pyeongtaek facility?
Production at Axcelis' new Pyeongtaek manufacturing facility is scheduled to commence in the second half of 2028. The site will expand its existing manufacturing operations in Korea.
How much is Axcelis investing in its new Korean manufacturing facility?
Axcelis is investing $35 million in the new Pyeongtaek facility. The project will encompass approximately 200,000 square feet of total gross floor area for ion implantation equipment manufacturing and supporting facilities.